CNO Financial Group, Inc. (NYSE:CNO) Q3 2021 Results Conference Call October 28, 2021 11:00 AM ET Company Participants Jennifer Childe - VP, IR and Sustainability Gary Bhojwani - CEO Paul McDonough - CFO Conference Call Participants Humphrey Lee - Dowling and Partners Cullen Johnson - B. Riley Securities Erik Bass - Autonomous Research John Barnidge - Piper Sandler Operator Good day, and thank you for standing by. Welcome to the CNO Financial Group Third Quarter 2021 Earnings Conference Call. [Operator Inst ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ to ___ Commission File Number 001-31792 CNO Financial Group, Inc. Delaware 75-3108137 | --- | --- | --- | |-------------------------------------------- ...

CNO Financial Group, Inc. (NYSE:CNO) Q2 2021 Earnings Conference Call July 29, 2021 11:00 AM ET Company Participants Jennifer Childe - VP, IR Gary Bhojwani - CEO Paul McDonough - CFO Conference Call Participants Colin Johnson - B. Riley Securities Hung-Fai Lee - Dowling and Partners Erik Bass - Autonomous Research John Barnidge - Piper Sandler Ryan Krueger - KBW Operator Good day and thank you for standing by. Welcome to the CNO Financial Group Second Quarter 2021 Earnings Call. All participants are in a li ...

Second Quarter 2021 Financial and operating results for the period ended June 30, 2021 July 28, 2021 Unless otherwise specified, comparisons in this presentation are between 2Q20 and 2Q21. Important Legal Information Forward-Looking Statements Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These include statements about future results of operations and capital plans. We caution investors that th ...

Investor Overview May 2021 Important Legal Information Forward-Looking Statements Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These include statements about future results of operations and capital plans. We caution investors that these forward-looking statements are not guarantees of future performance, and actual results may differ materially. Investors should consider the important risks a ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ to ___ Commission File Number 001-31792 CNO Financial Group, Inc. | --- | --- | --- | |--------------------------------------------------------------- ...

Financial Data and Key Metrics Changes - The company reported operating earnings per share of $0.55, or $0.59 excluding significant items, compared to $0.58 in the prior period, with no significant items in the prior period [6] - Book value per diluted share, excluding AOCI, grew by 13% [6] - The RBC ratio ended the quarter at 407%, with $324 million in cash at the holding company [7][28] - Operating earnings per share, excluding significant items, were up 2%, and return on equity improved by 60 basis points compared to the prior year [22] Business Line Data and Key Metrics Changes - Life sales increased by a record 29% for the quarter, driven by record direct-to-consumer sales and a significant increase in production from exclusive field agents [9] - Health sales were down 19% year-over-year, reflecting a shift from Medicare supplement towards Medicare Advantage [9] - Annuity collected premiums were up 11%, marking the second consecutive quarterly increase [10] - Client assets in brokerage and advisory grew 38% year-over-year to $2.4 billion, with net client asset inflows and market value appreciation [10] Market Data and Key Metrics Changes - Worksite sales were down 30% year-over-year, but showed sequential improvement, with March sales down only 11% year-over-year [15] - The company expects the Worksite Division to maintain sequential growth and return to year-over-year growth as workplaces reopen [15] Company Strategy and Development Direction - The company is focused on executing its strategic transformation initiated in January 2020, which includes growing the business profitably and launching new products [8] - The acquisition of DirectPath is expected to enhance the company's product offerings and cross-sell opportunities [18] - The company aims to deepen relationships with middle-income clients and has shifted its agent recruiting strategy to rely more on personal referrals [13] Management's Comments on Operating Environment and Future Outlook - Management noted that the adverse case scenario regarding COVID-19 appears increasingly unlikely, with favorable trends in infection and vaccination rates [29] - The company expects a modest net favorable COVID-related mortality and morbidity impact for the balance of 2021, with a potential spike in health care claims post-COVID [30] - Management emphasized the importance of maintaining a conservative capital and liquidity posture amid ongoing uncertainties [28] Other Important Information - The company returned $116 million to shareholders in the first quarter, including $100 million in share buybacks [19] - The 2020 corporate social responsibility report will be available soon, highlighting the company's ESG efforts [20] Q&A Session Summary Question: Long-term care claims experience and reserve releases - The favorable COVID impact in long-term care was $25 million, reflecting $9 million in benefit reserve releases and $16 million in reduced paid claims [37] Question: Updated guidance for underwriting - The company expects a net favorable COVID impact for the balance of 2021, with a return to normal claim patterns in Medicare Supplement and an increase in claims due to pent-up demand [40][41] Question: Buyback strategy and capital allocation - The company maintains a conservative posture regarding its RBC and liquidity targets but plans to gradually become less conservative as uncertainty diminishes [46] Question: Life sales and pandemic awareness - Increased consumer awareness due to the pandemic has contributed to life sales growth, alongside the benefits of the company's business transformation [50][51] Question: Home health care preference impact on claims - The company does not expect a material shift in claims costs between home health care and nursing home care due to the modest nature of the benefits offered [60] Question: Free cash flow and new business strain - New business strain will impact free cash flow, but the company expects to continue generating healthy levels of free cash flow [61]

First Quarter 2021 Financial and operating results for the period ended March 31, 2021 April 28, 2021 Unless otherwise specified, comparisons in this presentation are between 1Q20 and 1Q21. Important Legal Information Forward-Looking Statements Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These include statements about future results of operations and capital plans. We caution investors that t ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2020 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from ______ to ______ Commission File Number 001-31792 CNO Financial Group, Inc. Delaware 75-3108137 State of Incorporation IRS Employer Identification No. 11825 N. ...

CNO Financial Group, Inc. (NYSE:CNO) Q4 2020 Earnings Conference Call February 10, 2021 11:00 AM ET Company Participants Jennifer Childe - Vice President, Investor Relations Gary Bhojwani - Chief Executive Officer Paul McDonough - Chief Financial Officer Conference Call Participants Ryan Krueger - KBW John Barnidge - Piper Sandler Erik Bass - Autonomous Research Humphrey Lee - Dowling & Partners Randy Binner - B. Riley Securities John Barnidge - Piper Sandler Operator Ladies and gentlemen, thank you for sta ...